Evotec to Collaborate with Takeda Cambridge for Multi-target Hit Identification
Advertisement
Evotec AG announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and metabolic diseases.
Evotec will apply its state-of-the-art Screening Platform and proprietary GPCR modeling software to identify and validate novel modulators against various targets selected by Takeda Cambridge.
Dr Mario Polywka, Chief Operating Officer at Evotec stated: "We are proud to be selected by Takeda Cambridge to collaborate on this important project. We have invested significantly in our world leading, hit-identification platform and this alliance further validates the strength of this platform and Evotec's ability to bring value to its partner's drug discovery efforts. We look forward to working with Takeda Cambridge."
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Charles River Laboratories Acquires Distributed Bio

A tapeworm drug against COVID-19? - Charité conducts clinical trial to test potential new treatment

Covestro invests in start-ups - Five focus areas: Biotech, 3D printing, digitalization, circularity and new markets
University of Warwick Wins Domainex’s First Discovery STAR Award
Evogene Participates In Israeli Agbio Consortium - BIOTOV MAGNET Consortium to focus on improved Nutritional Qualities for Fruits and Vegetable

Revealing the secrets of cell competition - Which features distinguish “winner” from “loser” cells
BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies

Avoiding animal testing with vegan antibodies - Spin-off project "Ymolution" launched

A matter of timing - To bloom or not to bloom? Max Planck researchers discover how flowering time is affected by temperature

Peanut Allergy Prevention: Researchers Uncover Groundbreaking Solution
List_of_subjects_in_Gray's_Anatomy:_VI._The_Arteries
